Cargando…

Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer

Intestinal microorganisms are closely associated with immunity, metabolism, and inflammation, and play an important role in health and diseases such as inflammatory bowel disease, diabetes, cardiovascular disease, Parkinson’s disease, and cancer. Liver cancer is one of the most fatal cancers in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Chenchen, Xiao, Geqiong, Liu, Chunyan, Yan, Junwei, Chen, Jiaqi, Si, Wenzhang, Zhang, Jian, Liu, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693382/
https://www.ncbi.nlm.nih.gov/pubmed/34957088
http://dx.doi.org/10.3389/fcell.2021.702414
_version_ 1784619131691073536
author Bi, Chenchen
Xiao, Geqiong
Liu, Chunyan
Yan, Junwei
Chen, Jiaqi
Si, Wenzhang
Zhang, Jian
Liu, Zheng
author_facet Bi, Chenchen
Xiao, Geqiong
Liu, Chunyan
Yan, Junwei
Chen, Jiaqi
Si, Wenzhang
Zhang, Jian
Liu, Zheng
author_sort Bi, Chenchen
collection PubMed
description Intestinal microorganisms are closely associated with immunity, metabolism, and inflammation, and play an important role in health and diseases such as inflammatory bowel disease, diabetes, cardiovascular disease, Parkinson’s disease, and cancer. Liver cancer is one of the most fatal cancers in humans. Most of liver cancers are slowly transformed from viral hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease. However, the relationship between intestinal microbiota and their metabolites, including short-chain fatty acids, bile acids, indoles, and ethanol, and liver cancer remains unclear. Here, we summarize the molecular immune mechanism of intestinal microbiota and their metabolites in the occurrence and development of liver cancer and reveal the important role of the microbiota-gut-liver axis in liver cancer. In addition, we describe how the intestinal flora can be balanced by antibiotics, probiotics, postbiotics, and fecal bacteria transplantation to improve the treatment of liver cancer. This review describes the immunomolecular mechanism of intestinal microbiota and their metabolites in the occurrence and development of hepatic cancer and provides theoretical evidence support for future clinical practice.
format Online
Article
Text
id pubmed-8693382
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86933822021-12-23 Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer Bi, Chenchen Xiao, Geqiong Liu, Chunyan Yan, Junwei Chen, Jiaqi Si, Wenzhang Zhang, Jian Liu, Zheng Front Cell Dev Biol Cell and Developmental Biology Intestinal microorganisms are closely associated with immunity, metabolism, and inflammation, and play an important role in health and diseases such as inflammatory bowel disease, diabetes, cardiovascular disease, Parkinson’s disease, and cancer. Liver cancer is one of the most fatal cancers in humans. Most of liver cancers are slowly transformed from viral hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease. However, the relationship between intestinal microbiota and their metabolites, including short-chain fatty acids, bile acids, indoles, and ethanol, and liver cancer remains unclear. Here, we summarize the molecular immune mechanism of intestinal microbiota and their metabolites in the occurrence and development of liver cancer and reveal the important role of the microbiota-gut-liver axis in liver cancer. In addition, we describe how the intestinal flora can be balanced by antibiotics, probiotics, postbiotics, and fecal bacteria transplantation to improve the treatment of liver cancer. This review describes the immunomolecular mechanism of intestinal microbiota and their metabolites in the occurrence and development of hepatic cancer and provides theoretical evidence support for future clinical practice. Frontiers Media S.A. 2021-12-08 /pmc/articles/PMC8693382/ /pubmed/34957088 http://dx.doi.org/10.3389/fcell.2021.702414 Text en Copyright © 2021 Bi, Xiao, Liu, Yan, Chen, Si, Zhang and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Bi, Chenchen
Xiao, Geqiong
Liu, Chunyan
Yan, Junwei
Chen, Jiaqi
Si, Wenzhang
Zhang, Jian
Liu, Zheng
Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title_full Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title_fullStr Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title_full_unstemmed Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title_short Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
title_sort molecular immune mechanism of intestinal microbiota and their metabolites in the occurrence and development of liver cancer
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693382/
https://www.ncbi.nlm.nih.gov/pubmed/34957088
http://dx.doi.org/10.3389/fcell.2021.702414
work_keys_str_mv AT bichenchen molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT xiaogeqiong molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT liuchunyan molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT yanjunwei molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT chenjiaqi molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT siwenzhang molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT zhangjian molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer
AT liuzheng molecularimmunemechanismofintestinalmicrobiotaandtheirmetabolitesintheoccurrenceanddevelopmentoflivercancer